<bill session="116" type="s" number="946" updated="2019-06-27T10:56:13Z">
  <state datetime="2019-03-28">REFERRED</state>
  <status>
    <introduced datetime="2019-03-28"/>
  </status>
  <introduced datetime="2019-03-28"/>
  <titles>
    <title type="official" as="introduced">A bill to direct the Comptroller General of the United States to complete a study on barriers to participation in federally funded cancer clinical trials by populations that have been traditionally underrepresented in such trials.</title>
    <title type="short" as="introduced">Henrietta Lacks Enhancing Cancer Research Act of 2019</title>
    <title type="short" as="introduced">Henrietta Lacks Enhancing Cancer Research Act of 2019</title>
    <title type="display">Henrietta Lacks Enhancing Cancer Research Act of 2019</title>
  </titles>
  <sponsor bioguide_id="V000128"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-03-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-28">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-03-28" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="1966"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government studies and investigations"/>
    <term name="Medical research"/>
    <term name="Minority health"/>
    <term name="Public participation and lobbying"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
